CCNF and amyotrophic lateral sclerosis: Here, we thereby demonstrate a proof-of-concept proteogenomic workflow to screen new gene mutations (using CCNF as an example) to determine their potential to cause apoptosis and ALS pathogenesis using a combination of in vitro and in vivo models, proteomics, and biochemical assays.